Modern Critical Care Endocrinology, An Issue of Critical Care Clinics, 1st Edition
Author :
By Rinaldo Bellomo, MBBS(Hons), MD, FRACP, FCCP
This issue of Critical Care Clinics, Guest Edited by Dr. Rinaldo Bellomo, focuses on Modern Critical Care Endocrinology. Article topics include: Diabetes insipidus and SIADH in the ICU; Estrogen therapy in ICU patients; The angiotensin family, ACE
...view more
This issue of Critical Care Clinics, Guest Edited by Dr. Rinaldo Bellomo, focuses on Modern Critical Care Endocrinology. Article topics include: Diabetes insipidus and SIADH in the ICU; Estrogen therapy in ICU patients; The angiotensin family, ACE and ACE 2; Angiotensin II in vasodilatory shock; Vasopressin in vasodilatory shock; Hydrocortisone in vasodilatory shock; Erythropoietin in trauma and critical illness; HbA1c and permissive hyperglycemia in diabetic ICU patients; Osteoporosis and the critically ill patient; New oral agents for the treatment of diabetes; Melatonin in critical care; The incretins in ICU patients; Hepcidin; Thyroid hormone therapy in the ICU; and Hormonal therapy in organ donors.
This issue of Critical Care Clinics, Guest Edited by Dr. Rinaldo Bellomo, focuses on Modern Critical Care Endocrinology. Article topics include: Diabetes insipidus and SIADH in the ICU; Estrogen therapy in ICU patients; The angiotensin family, ACE and ACE 2; Angiotensin II in vasodilatory shock; Vasopressin in vasodilatory shock; Hydrocortisone in vasodilatory shock; Erythropoietin in trauma and critical illness; HbA1c and permissive hyperglycemia in diabetic ICU patients; Osteoporosis and the critically ill patient; New oral agents for the treatment of diabetes; Melatonin in critical care; The incretins in ICU patients; Hepcidin; Thyroid hormone therapy in the ICU; and Hormonal therapy in organ donors.
Author Information
By Rinaldo Bellomo, MBBS(Hons), MD, FRACP, FCCP, Chairman, Australian and New Zealand Intensive Care Society Clinical Trials Group and Director of Intensive Care Research, Department of Intensive Care, Austin & Repatriation Medical Centre, Melbourne, Victoria, Australia
By Rinaldo Bellomo, MBBS(Hons), MD, FRACP, FCCP, Chairman, Australian and New Zealand Intensive Care Society Clinical Trials Group and Director of Intensive Care Research, Department of Intensive Care, Austin & Repatriation Medical Centre, Melbourne, Victoria, Australia
https://www.elsevierhealth.com.au/modern-critical-care-endocrinology-an-issue-of-critical-care-clinics-9780323677912.html296286Modern Critical Care Endocrinology, An Issue of Critical Care Clinicshttps://www.elsevierhealth.com.au/media/catalog/product/9/7/9780323677912_6.jpg110.97147.95AUDInStock/Medicine & Surgery/Critical Care/Clinics/Medicine/Critical Care/Clinics/Clinics/Medicine/Critical Care/Japan Titles43351044388725505456850546665255041525984952631601418269243350884886536505455351451205259833This issue of Critical Care Clinics, Guest Edited by Dr. Rinaldo Bellomo, focuses on Modern Critical Care Endocrinology. Article topics include: Diabetes insipidus and SIADH in the ICU; Estrogen therapy in ICU patients; The angiotensin family, ACE and ACE 2; Angiotensin II in vasodilatory shock; Vasopressin in vasodilatory shock; Hydrocortisone in vasodilatory shock; Erythropoietin in trauma and critical illness; HbA1c and permissive hyperglycemia in diabetic ICU patients; Osteoporosis and the critically ill patient; New oral agents for the treatment of diabetes; Melatonin in critical care; The incretins in ICU patients; Hepcidin; Thyroid hormone therapy in the ICU; and Hormonal therapy in organ donors. This issue of Critical Care Clinics, Guest Edited by Dr. Rinaldo Bellomo, focuses on Modern Critical Care Endocrinology. Article topics include: Diabetes insipidus and SIADH in the ICU; Estrogen therapy in ICU patients; The angiotensin family, ACE and ACE 2; Angiotensin II in vasodilatory shock; Vasopressin in vasodilatory shock; Hydrocortisone in vasodilatory shock; Erythropoietin in trauma and critical illness; HbA1c and permissive hyperglycemia in diabetic ICU patients; Osteoporosis and the critically ill patient; New oral agents for the treatment of diabetes; Melatonin in critical care; The incretins in ICU patients; Hepcidin; Thyroid hormone therapy in the ICU; and Hormonal therapy in organ donors.00add-to-cart97803236779122019ProfessionalBy Rinaldo Bellomo, MBBS(Hons), MD, FRACP, FCCP20191Book152w x 229h (6.00" x 9.00")Elsevier027 Mar 2019Please allow 10-14 working days for deliveryBy <STRONG>Rinaldo Bellomo</STRONG>, MBBS(Hons), MD, FRACP, FCCP, Chairman, Australian and New Zealand Intensive Care Society Clinical Trials Group and Director of Intensive Care Research, Department of Intensive Care, Austin & Repatriation Medical Centre, Melbourne, Victoria, AustraliaClinicsClinicsThe Clinics: Internal MedicineUnited StatesNoNoNoNoPlease SelectPlease SelectPlease Select
